Practical recommendations for the use of beta-blockers in chronic obstructive pulmonary disease.

Published in: Expert review of respiratory medicine (2020)

Beta-blockers should not be used to treat COPD patients who do not have conditions with clear guideline-directed recommendations for their use. Vigilance is recommended in prescribing these medications for indications where another drug class could be utilized.

Keyphrases

angiotensin converting enzyme
clinical practice
chronic obstructive pulmonary disease
primary care
adverse drug
lung function
angiotensin ii
drug induced